Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Poor Performance Status”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00456612
What this trial is testing

Radiosurgery for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Beth Israel Deaconess Medical Center 4
Early research (Phase 1)Ended earlyNCT00287859
What this trial is testing

Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05673187
What this trial is testing

Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status

Who this might be right for
NSCLC Stage IVKRAS P.G12C
ETOP IBCSG Partners Foundation 68
Testing effectiveness (Phase 2)Ended earlyNCT01474551
What this trial is testing

Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT01415011
What this trial is testing

Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University College, London 39
Testing effectiveness (Phase 2)Study completedNCT00193479
What this trial is testing

Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
SCRI Development Innovations, LLC 51
Testing effectiveness (Phase 2)Study completedNCT00892710
What this trial is testing

Trial of Poor Performance Status Patients (ToPPS)

Who this might be right for
Non Small Cell Lung Cancer
SCRI Development Innovations, LLC 172
Not applicableStudy completedNCT05166564
What this trial is testing

The PROtein Enriched MEDiterranean Diet and EXercise Trial for Older Adults At Risk of Undernutrition

Who this might be right for
Cognitive ImpairmentPoor NutritionCognitive Decline
Queen's University, Belfast 105
Testing effectiveness (Phase 2)Looking for participantsNCT05589818
What this trial is testing

Pembrolizumab for Advanced NSCLC and PS 2-3

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Icahn School of Medicine at Mount Sinai 45
Testing effectiveness (Phase 2)Study completedNCT02376322
What this trial is testing

Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS

Who this might be right for
Bone Metastases
Santa Casa de Porto Alegre 50
Testing effectiveness (Phase 2)Study completedNCT01242566
What this trial is testing

Temozolomide in Elderly Patients With KPS < 70

Who this might be right for
Primary Brain TumorGlioblastoma
Assistance Publique - Hôpitaux de Paris 70
Large-scale testing (Phase 3)Study completedNCT01459497
What this trial is testing

Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center 103
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07796126
What this trial is testing

Sequential Toripalimab and Paclitaxel in Patients With Head and Neck Squamous Cell Cancer (HNSCC) and Poor Performance Status

Who this might be right for
Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
Barbara Ann Karmanos Cancer Institute 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07398560
What this trial is testing

Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

Who this might be right for
Small Cell Lung Cancer
The Third Affiliated Hospital of Harbin Medical University 47
Not applicableStudy completedNCT05634551
What this trial is testing

Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status

Who this might be right for
Non-small Cell Lung Cancer
M.D. Anderson Cancer Center 15
Early research (Phase 1)Study completedNCT01839981
What this trial is testing

CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Wake Forest University Health Sciences 10
Testing effectiveness (Phase 2)Study completedNCT00085839
What this trial is testing

Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2

Who this might be right for
Non-Small Cell Lung Cancer
OSI Pharmaceuticals 103
Testing effectiveness (Phase 2)Study completedNCT00124618
What this trial is testing

Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 58
Testing effectiveness (Phase 2)Study completedNCT00193323
What this trial is testing

Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients

Who this might be right for
Lung Cancer
SCRI Development Innovations, LLC 346
Testing effectiveness (Phase 2)Study completedNCT00891878
What this trial is testing

Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
Alliance for Clinical Trials in Oncology 12
Next Page